<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0535-5133</journal-id>
<journal-title><![CDATA[Investigación Clínica]]></journal-title>
<abbrev-journal-title><![CDATA[Invest. clín]]></abbrev-journal-title>
<issn>0535-5133</issn>
<publisher>
<publisher-name><![CDATA[Instituto de Investigaciones Clínicas "Dr. Américo Negrette", Facultad de Medicina, Universidad del Zulia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0535-51332009000100009</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Proliferation and bystander suppression induced by membrane and flagellar antigens of Trypanosoma cruzi]]></article-title>
<article-title xml:lang="es"><![CDATA[Proliferación y supresión circunstancial inducida por antígenos de flagelo y membrana de Trypanosoma cruzi]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[Walter]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Briceño]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad Central de Venezuela Facultad de Medicina Instituto de Biomedicina]]></institution>
<addr-line><![CDATA[Caracas ]]></addr-line>
<country>Venezuela</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2009</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2009</year>
</pub-date>
<volume>50</volume>
<numero>1</numero>
<fpage>77</fpage>
<lpage>87</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_arttext&amp;pid=S0535-51332009000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_abstract&amp;pid=S0535-51332009000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_pdf&amp;pid=S0535-51332009000100009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[We have studied, in vitro, proliferation induced by flagella (FE) and membrane (ME) antigenic fractions of T. cruzi epimastigotes, as well as their regulatory effect on the proliferative response to PPD (Protein Purified Derivative). Crude flagella as well as bands from Western blots of flagella and membrane of epimastigotes were tested. Crude flagella elicited higher proliferation in mononuclear cells from patients with Chagasic cardiomyopathy (CDM) than in patients with no evidence of cardiac pathology (INF). Fractionated antigens induced a lower proliferative response, in intensity as well as in frequency, than the crude extracts. With FE, bands between 150 and 24.3 kDa (B3 to B18 with the exception of B4 and B13) induced higher CPM (Counts Per Minute) in CDM. In INF only bands B7 (87.3 to 80.1 kDa), 9 (69.8 to 64.6 kDa) and 13 (45.4 to 41.5 kDa) had high CPM. ME bands also elicited higher proliferation in CDM. However, only 5 out of 14 bands gave CPM higher than 1000 in CDM and none in INF. The mean down regulation (DR) of most bands was similar in both groups. But the frequency of relevant DR elicited by FE was significantly higher in CDM. In contrast the frequency of up regulation (UR) was higher in INF. Bands 13 and 14 of ME did not induce DR in most INF. The discordance between the frequency of relevant DR in CDM and INF was more evident with ME than with FE. The frequency of (UR) was 50% or higher with all ME bands in INF, but, lower than 12% in CDM. The higher UR in INF and of DR in CDM, suggest the presence of some balance or interaction in INF that is lost in CDM. In ME there might be antigens that could be relevant for the immunoprofilaxis of Chagas' disease. The difference in the clinical status of the two groups seems to be associated with the recognition of different groups of antigens together with variations in the nature of the regulation of the response of mononuclear cells to these antigens.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Hemos estudiado, in vitro, la respuesta proliferativa de células mononucleares a antígenos de Flagelo (FE) y Membrana (ME) de epimastigotes de T. cruzi, así como su efecto regulador en la respuesta proliferativa a PPD (Protein Purified derivative). Fue evaluada tanto la respuesta a Flagelo crudo como a las bandas de Western blots de FE y ME. El flagelo crudo indujo una proliferación de las células mononucleares más intensa en los pacientes con cardiomiopatía (CDM) que en los pacientes sin evidencia de patología cardiaca (INF). Los antígenos fraccionados causaron una menor respuesta proliferativa, tanto en intensidad como en frecuencia, que los antígenos crudos. Las bandas de FE, entre 150 y 24,3 kDa (B3 a B18 con la excepción de B4 y B13), indujeron CPM mas altas en CDM. En INF solo las bandas B7 (87,3 a 80,1 kDa), 9 (69,8 a 64,6 kDa) y 13 (45,4 a 41,5 kDa) causaron CPM (Cuentas Por Minuto) altas. Las bandas de ME también indujeron una proliferación mayor en CDM. Sin embargo, solo 5 de 14 bandas tuvieron CPM promedio mayores de 1000 en INF. La mayor parte de las bandas causaron una baja regulación (BR) que fue similar en ambos grupos. Sin embargo, la frecuencia de BR relevante producida por FE fue significativamente mayor en CDM. Por el contrario la sobre regulación (SB) fue mayor en INF. Las bandas 13 y 14 de ME no indujeron BR en la mayor parte de los INF. La discordancia entre la frecuencia de BR relevante en CDM e INF fue mas evidente con ME que con FE. La frecuencia de SB fue 50% o mas con todas las bandas de ME en INF, pero menor que 12% en los CDM. El predominio de SB en INF y de BR en CDM sugiere la presencia, en los INF, de algún tipo de equilibrio o interacción que esta ausente en los CDM. En ME pudieran estar presente antígenos relevantes para la inmunoprofilaxis de la enfermedad de Chagas. En conjunto nuestros resultados sugieren que las diferencias en los cuadros clínicos pudieran tener relación con la respuesta observada a los diferentes antígenos tanto a nivel de regulación como de proliferación.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Chagas' disease]]></kwd>
<kwd lng="en"><![CDATA[membrane]]></kwd>
<kwd lng="en"><![CDATA[flagella]]></kwd>
<kwd lng="en"><![CDATA[regulation]]></kwd>
<kwd lng="en"><![CDATA[cellular immunity]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad de Chagas]]></kwd>
<kwd lng="es"><![CDATA[membrana]]></kwd>
<kwd lng="es"><![CDATA[flagelo]]></kwd>
<kwd lng="es"><![CDATA[regulación]]></kwd>
<kwd lng="es"><![CDATA[inmunidad celular]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[  <BASEFONT SIZE="3"> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="center"><FONT COLOR="#1f1a17" FACE="Verdana"> <B>Proliferation and bystander suppression induced by membrane and flagellar  antigens of </B><I><B>Trypanosoma cruzi.</B></I><B>&nbsp;</B> </FONT></P>     <P ALIGN="center"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Walter Mosca and Luis Brice&#241;o.</FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Laboratorio de Fisiopatolog&#237;a, Instituto de Biomedicina, Facultad de Medicina,  Universidad Central de Venezuela, Apartado 4043, Caracas 1010A, Venezuela.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Corresponding author: Walter Mosca. Instituto de Biomedicina, Apartado  4043. Caracas 1010A, Venezuela. Telephone 58-212-8604636; 8604630, Fax  58-212-8611258. E-mail: <a href="mailto:wmosca@gmail.com">wmosca@gmail.com</a></FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Abstract. </B>We have studied, <I>in vitro, </I>proliferation induced by flagella  (FE) and membrane (ME) antigenic fractions of T. cruzi epimastigotes, as  well as their regulatory effect on the proliferative response to PPD (Protein  Purified Derivative). Crude flagella as well as bands from Western blots  of flagella and membrane of epimastigotes were tested. Crude flagella elicited  higher proliferation in mononuclear cells from patients with Chagasic cardiomyopathy  (CDM) than in patients with no evidence of cardiac pathology (INF). Fractionated  antigens induced a lower proliferative response, in intensity as well as  in frequency, than the crude extracts. With FE, bands between 150 and 24.3  kDa (B3 to B18 with the exception of B4 and B13) induced higher CPM (Counts  Per Minute) in CDM. In INF only bands B7 (87.3 to 80.1 kDa), 9 (69.8 to  64.6 kDa) and 13 (45.4 to 41.5 kDa) had high CPM. ME bands also elicited  higher proliferation in CDM. However, only 5 out of 14 bands gave CPM higher  than 1000 in CDM and none in INF. The mean down regulation (DR) of most  bands was similar in both groups. But the frequency of relevant DR elicited  by FE was significantly higher in CDM. In contrast the frequency of up  regulation (UR) was higher in INF. Bands 13 and 14 of ME did not induce  DR in most INF. The discordance between the frequency of relevant DR in  CDM and INF was more evident with ME than with FE. The frequency of (UR)  was 50% or higher with all ME bands in INF, but, lower than 12% in CDM.  The higher UR in INF and of DR in CDM, suggest the presence of some balance  or interaction in INF that is lost in CDM. In ME there might be antigens  that could be relevant for the immunoprofilaxis of Chagas' disease. The  difference in the clinical status of the two groups seems to be associated  with the recognition of different groups of antigens together with variations  in the nature of the regulation of the response of mononuclear cells to  these antigens.</FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Key words:&nbsp;</B>Chagas' disease, membrane, flagella, regulation, cellular immunity&nbsp;</FONT></P> </MULTICOL> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="center"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Proliferaci&#243;n y supresi&#243;n circunstancial inducida por ant&#237;genos de flagelo  y membrana de </B><I><B>Trypanosoma cruzi.</B></I></FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Resumen.</B> Hemos estudiado,<I> in vitro,</I> la respuesta proliferativa de c&#233;lulas  mononucleares a ant&#237;genos de Flagelo (FE) y Membrana (ME) de epimastigotes  de T. cruzi, as&#237; como su efecto regulador en la respuesta proliferativa  a PPD (Protein Purified derivative). Fue evaluada tanto la respuesta a  Flagelo crudo como a las bandas de Western blots de FE y ME. El flagelo  crudo indujo una proliferaci&#243;n de las c&#233;lulas mononucleares m&#225;s intensa  en los pacientes con cardiomiopat&#237;a (CDM) que en los pacientes sin evidencia  de patolog&#237;a cardiaca (INF). Los ant&#237;genos fraccionados causaron una menor  respuesta proliferativa, tanto en intensidad como en frecuencia, que los  ant&#237;genos crudos. Las bandas de FE, entre 150 y 24,3 kDa (B3 a B18 con  la excepci&#243;n de B4 y B13), indujeron CPM mas altas en CDM. En INF solo  las bandas B7 (87,3 a 80,1 kDa), 9 (69,8 a 64,6 kDa) y 13 (45,4 a 41,5  kDa) causaron CPM (Cuentas Por Minuto) altas. Las bandas de ME tambi&#233;n  indujeron una proliferaci&#243;n mayor en CDM. Sin embargo, solo 5 de 14 bandas  tuvieron CPM promedio mayores de 1000 en INF. La mayor parte de las bandas  causaron una baja regulaci&#243;n (BR) que fue similar en ambos grupos. Sin  embargo, la frecuencia de BR relevante producida por FE fue significativamente  mayor en CDM. Por el contrario la sobre regulaci&#243;n (SB) fue mayor en INF.  Las bandas 13 y 14 de ME no indujeron BR en la mayor parte de los INF.  La discordancia entre la frecuencia de BR relevante en CDM e INF fue mas  evidente con ME que con FE. La frecuencia de SB fue 50% o mas con todas  las bandas de ME en INF, pero menor que 12% en los CDM. El predominio de  SB en INF y de BR en CDM sugiere la presencia, en los INF, de alg&#250;n tipo  de equilibrio o interacci&#243;n que esta ausente en los CDM. En ME pudieran  estar presente ant&#237;genos relevantes para la inmunoprofilaxis de la enfermedad  de Chagas. En conjunto nuestros resultados sugieren que las diferencias  en los cuadros cl&#237;nicos pudieran tener relaci&#243;n con la respuesta observada  a los diferentes ant&#237;genos tanto a nivel de regulaci&#243;n como de proliferaci&#243;n.</FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Palabras clave:&nbsp;</B>Enfermedad de Chagas, membrana, flagelo, regulación,  inmunidad celular.</FONT></P>     ]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Recibido: 15-05-2008. Aceptado: 06-10-2008.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>INTRODUCTION&nbsp;</B> </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Chagas' disease is a parasitic zoonosis, endemic in Central and South America,  caused by the protozoan parasite <I>Trypanosoma cruzi.</I> According to the World  Health Organization (1), there are 18 million people infected with <I>T. cruzi</I>  in Latin America. Thirty percent of these have, or will develop, a chronic  cardiomyopathy that will limit their productive capacity and require medical  care.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Since <I>T. cruzi</I> is an intracellular parasite, the cell-mediated immune response  plays a central role in its control. This aspect has been evaluated in  numerous studies (2-7), all of which have shown,<I> in vitro,</I> proliferation  of mononuclear cells stimulated with <I>T. cruzi</I> antigens. The existence of  suppression of the immune response has been reported in experimental models  (7-12) as well as in Chagas' disease patients (7, 13).&nbsp; </FONT></P> </MULTICOL> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Recently, a proline racemase of the parasite has been described whose activity  seems to be essential for B-cell mitogenicity and the induction of the  suppression observed during the acute phase of the experimental infection  of mice (14). Furthermore, it has been reported that the frequency of natural  regulatory cells (CD4+CD25+), in peripheral blood, is higher in INF than  in CDM (15, 16).&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Antigens recognized by the immune system play an important role in determining  the characteristics of the host response. Antigenic determinants that selectively  activate<I> in vivo </I>T cells with either helper or suppressor activity have  been shown in several antigens (17, 18). Miller <I>et al.</I> (19) reported that  cells from rats made tolerant by oral administration of antigen, down-regulate  the response to a different antigen, to which the animal is immune, when  stimulated with both antigens. This effect was termed &quot;bystander suppression&quot;.  Using an<I> in vitro</I> assay, we have demonstrated that <I>T. cruzi </I>antigens induce  bystander suppression of the proliferative response to PPD or tetanus toxoid  (13). On the other hand, Rowland <I>et al.</I> (20), have shown that resistance  or susceptibility of mice to<I> T. cruzi </I>infection is associated with the  response to different antigens. Other studies have shown that immunization  with a soluble antigen induces pathology, while a flagellar antigen elicits  protective immunity (21-23). These studies suggest that in Chagas' disease,  the outcome of the host-parasite interaction depends on the balance established  between the effector and regulatory immune response elicited by different  parasite antigens.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> In a previous publication (24) we have demonstrated that the proliferative  response of mononuclear cells from patients with Chagas' disease to bands  of soluble, epimastigotes and trypomastigotes, antigens was poor with an  important down regulation (DR) that was more frequent and intense with  soluble antigens of trypomastigotes. The epimastigotes antigen used corresponds  to the cell sap antigen reported as pathogenic and no protective. Because  Ruiz <I>et al.</I> (23) have reported that the fraction of flagella induce an  important protection we decided to study this fraction and the antigens  of membrane of epimastigotes to see if they elicited a better response  in mononuclear cells of patients. Surprisingly, Bands of FE induced a response  compatible with our previous results with soluble antigens. However, with  ME bands few patients with no evidence of cardiac pathology (INF) had a  relevant DR and all ME bands gave a significant up regulation (UR) in more  than 50 percent of the INF evaluated.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>MATERIALS AND METHODS&nbsp;</B> </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Patient groups</B>&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Patients were selected from the Cardiology Clinic for Chagas' disease at  the Vargas Hospital in Caracas, Venezuela. A total of 36 patients (23 males,  13 females), with positive serology to <I>T. cruzi </I>antigens, agreed to participate  in this study. Patients were classified into two groups according to previous  criteria (25). The 17 patients assigned to group I (INF) were seropositive  for <I>T. cruzi</I> with no evidence of heart disease (mean age 47 years; range  32 to 63 years). The 19 patients assigned to group II, Chagasic cardiomyopathy,  (CDM) presented electrocardiographic abnormalities characteristic of either  complete right bundle branch block plus anterior or posterior hemiblock  of the left bundle, or complete atrioventricular block with wide QRS complex  (mean age 52 years; range 28 to 72 years).&nbsp; </FONT></P> </MULTICOL> <MULTICOL GUTTER="31" COLS="2">     ]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Antigens</B>&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Antigen A. </B>Y strain epimastigotes were grown in 199 medium supplemented  with 2% fetal calf serum. The parasites were harvested by centrifugation  at 400 g for 20 minutes and washed twice with PBS. After the last wash,  they were adjusted to 30 &#215; 10<SUP>6</SUP>/mL and autoclaved for 10 min (25); 20 &#181;L  of this suspension were added to each culture well.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>PPD (Protein Purified Derivative) (Statens Serum Institut, Denmark). </B>Protein  purified derivative (10 &#181;g/mL), 20 &#181;L/well.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Flagella (FE).</B> The flagella subcellular fraction of epimastigotes of <I>Trypanosoma  cruzi, </I>strain Y, were prepared as described by Piras <I>et al.</I> (26). Briefly,  parasites were adjusted to a concentration of 3&#215;10<SUP>8</SUP>/mL in a solution of  0.32 M sucrose, 1% albumin, 0.1mM CaCl2. Sonicated with a Branson ultrasonicator  (65 W for 30 seconds) using a microtip probe. After two cycles of sonication  the quality of the preparation was evaluated by observation with a phase  contrast microscope. Flagella were purified by differential centrifugation  in a discontinuous gradient of sucrose. The purified flagella were evaluated  with a phase contrast microscope and, if found to be adequate, used to  prepare the flagella antigen.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Membrane (ME).</B> The proteins from the membranes of epimastigotes were obtained  by extraction with Triton X-114 as described by Bordier <I>et al. </I>(27).&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Preparation of antigens adsorbed to nitrocellulose particles</B>&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Proteins in antigen samples were resolved by SDS-PAGE using a discontinuous  buffer system (28). Either FE or ME (3 mg per gel) were applied to 10%  acrylamide gels using a blank comb with a single reference well for molecular  weight markers (Sigma Chemical Co. USA) for the determination of molecular  mass. They were run under reducing and denaturalizing conditions, and transferred  to nitrocellulose membranes (NC) by the method of Towbin <I>et al.</I> (29). The  Western blots were stained with Ponceau red (Sigma Chemical Co. USA) to  identify the protein bands. The stained and unstained bands were marked,  excised, cut into 63.3 mm<SUP>2</SUP> pieces and processed as described (24). After  washing with PBS, the resulting NC particles were suspended in 5 mL RPMI  1640; 100 &#181;L of this suspension were added to each culture well. The molecular  weight (mw) range of the bands is shown in <a href="#TABLE_I">Table I</a>.</FONT></P> </MULTICOL>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B><a name="TABLE_I">TABLE I</a></B></FONT></P>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> RANGE OF MOLECULAR WEIGHTS OF WESTERN BLOTS BANDS&nbsp; </FONT></P>     <div align="center"> <TABLE cellspacing="1" width="578" border="1" id="table1"> <TR> <TD WIDTH="121" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Bands&nbsp; </FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Flagella&nbsp; </FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Membrane&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Upper&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Lower&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Upper&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Lower&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 1&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 219.17&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 192.50&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 207.73&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 149.99&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 2&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 192.50&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 150.00&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 149.99&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 109.09&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 3&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 150.00&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 118.28&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 109.09&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 91.70&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 4&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 118.28&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 103.89&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;91.70&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 80.69&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 103.89&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;99.23&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;80.69&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71.87&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;99.23&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;87.33&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;71.87&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 65.10&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;87.33&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;80.14&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;65.10&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 53.67&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;80.14&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;69.83&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;53.67&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 47.23&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 9&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;69.83&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;64.60&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;47.23&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 39.51&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 10&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;64.60&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;59.41&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;39.51&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 30.67&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;59.14&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;53.98&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;30.67&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 26.03&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;53.98&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;45.37&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;26.03&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21.93&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;45.37&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;41.47&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;21.93&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 18.08&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;41.47&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;37.84&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;18.08&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14.91&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;37.84&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;33.23&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp; </font></TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;33.23&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;29.95&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;29.95&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;27.66&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 18&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;27.66&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;24.32&nbsp; </FONT></P> </TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="121" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> </TABLE> </div> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Cell proliferation assays. A standard microtest procedure was employed</B>&nbsp; </FONT></P>     ]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Briefly, mononuclear cells were separated from heparinized blood by centrifugation  over Ficoll-Hypaque, washed three times, and cultured in triplicate for  crude antigens and in quadruplicate for semi purified antigens, in plastic  microtiter plates, at a concentration of 2 &#215; 10<SUP>5</SUP> cells/ well. The medium  used was RPMI-1640 (Grand Island Biological Company) supplemented with  50 &#181;g/mL gentamycin and 10% autologous serum. After seven days of exposure  to the antigen(s), 0.5 &#181;Ci of [<SUP>3</SUP>H] thymidine was added to each well 18  hours before harvesting onto glass fiber strips and counting by liquid  scintillation. As control, particles of nitrocellulose (NC) without protein,  obtained from the same blot as the bands, were added to 10 wells with mononuclear  cells.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Evaluation of regulation induced by </B><I><B>T. cruzi </B></I><B>antigen</B>&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> To evaluate the regulation elicited by parasite antigens, mixtures of antigens  or nitrocellulose particles from Western blots and soluble PPD were used  at the same concentrations as for the cell proliferation assay.&nbsp; </FONT></P> </MULTICOL> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> The percentage of DR or UR was calculated as follows:&nbsp; </FONT></P>     <P ALIGN="justify"> <img border="0" src="/img/fbpe/ic/v50n1/art09ec1.gif" width="325" height="85"></P>     
<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Regulation was evaluated only in patients with a significant proliferation  to PPD (FE: INF 14, CDM 13; ME: INF 13, CDM 17).&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Data analysis: </B>criteria used to define relevant proliferation or regulation  induced by NC adsorbed antigen as relevant.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Proliferation: </B>Any band that gave a CPM greater than the mean plus two  standard deviations of the CPM induced by NC alone.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Regulation: </B>any regulation equal to or smaller than &#150;10 (Down-regulation),  or equal to or greater than 10 (Up-regulation) was considered relevant.  Only patients with a relevant proliferation to PPD were included in this  analysis.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B>Statistical analysis</B>&nbsp; </FONT></P>     ]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> The following parameters were used to compare the regulation induced by  bands of the sub cellular fractions:&nbsp; </FONT></P>     <p align="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">- Mean regulation: Average of relevant up or down regulation to the band.</FONT></MULTICOL></p> <MULTICOL GUTTER="31" COLS="2">     <p align="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">- Frequency of relevant up or down-regulation: percentage of patients with  relevant regulation to each band.&nbsp; </FONT></p>     <p align="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">- The frequency of responses to crude antigens was evaluated using a Chi  square test.&nbsp; </FONT></p>     <p align="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">- The paired Wilcoxon signed-rank test was used to compare: percentage of  patients with positive proliferation, mean values of down-regulation or  up-regulation.&nbsp; </FONT></p>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>RESULTS&nbsp;</B> </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>Analysis of the response of patients to crude antigens</B>&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>Proliferation.</B> The proliferative response to crude antigens was evaluated  with antigen A, the standard <I>T. cruzi </I>antigen used in our laboratory, and  Flagella (FE) adsorbed to NC. The ME antigen was not evaluated because  the presence of detergent minimize its adsorption to NC.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">The proliferative response induced by antigen A was higher in CDM than  in INF (<a href="#TABLE_II">Table II</a>) without reaching the level of significance (p= 0.06).  The CPM induced by FE were lower than with A but the tendency was similar,  higher in CDM than in INF. The frequency of relevant proliferation with  FE was similar in both groups.</FONT></P></MULTICOL>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B><a name="TABLE_II">TABLE II</a></B></FONT></P>     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> MEAN PROLIFERATION INDUCED BY CRUDE ANTIGENS&nbsp; </FONT></P>     <div align="center"> <TABLE cellspacing="1" width="452" border="1" id="table2"> <TR> <TD WIDTH="105" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Groups&nbsp; </FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Antigens&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="164" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> A&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> FE&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <p align="center"><font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="165" VALIGN="TOP">     <p align="center"><font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;CPM&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21738&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 4353&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;SEM&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5253&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 1232&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;N&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;14&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;15&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <p align="center"><font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="165" VALIGN="TOP">     ]]></body>
<body><![CDATA[<p align="center"><font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;CPM&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14416&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 2377&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;SEM&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;5898&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;612&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="105" VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;n&nbsp; </FONT></P> </TD> <TD WIDTH="164" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18&nbsp; </FONT></P> </TD> <TD WIDTH="165" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;&nbsp;&nbsp;&nbsp;19&nbsp; </FONT></P> </TD> </TR> </TABLE> </div>     ]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> SEM: Standard Error of the mean. &nbsp;&nbsp;&nbsp;FE: Flagella epimastigotes.&nbsp; </FONT></P> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>Regulation.  </B>As reported (24) any value equal or lower than &#150;10 was considered  a relevant DR, and any value equal or higher than 10 a relevant UR.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">The intensity of the DR of the response to PPD, induced by FE was similar  in both experimental groups (<a href="#TABLE_III">Table III</a>). The UR by FE was higher in CDM  than in INF, but this difference was not statistically significant.</FONT></P> </MULTICOL>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B><a name="TABLE_III">TABLE III</a></B></FONT></P>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> REGULATION INDUCED BY FLAGELLA&nbsp; </FONT></P>     <div align="center"> <TABLE cellspacing="1" width="422" border="1" id="table3"> <TR> <TD WIDTH="135" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Regulation&nbsp; </FONT></P> </TD> <TD WIDTH="140" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM&nbsp; </FONT></P> </TD> <TD VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="135" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> DR&nbsp; </FONT></P> </TD> <TD WIDTH="140" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &#150;41.5&nbsp; </FONT></P> </TD> <TD VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &#150;50.5&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="135" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> %DR&nbsp; </FONT></P> </TD> <TD WIDTH="140" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 75.0&nbsp; </FONT></P> </TD> <TD VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 64.3&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="135" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="140" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> (9/12)&nbsp; </FONT></P> </TD> <TD VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> (9/14)&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="135" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> UR&nbsp; </FONT></P> </TD> <TD WIDTH="140" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 108.7&nbsp; </FONT></P> </TD> <TD VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 72.9&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="135" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> %UR&nbsp; </FONT></P> </TD> <TD WIDTH="140" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 25.0&nbsp; </FONT></P> </TD> <TD VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35.7&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="135" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="140" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> (3/12)&nbsp; </FONT></P> </TD> <TD VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> (5/14)&nbsp; </FONT></P> </TD> </TR> </TABLE> </div>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> DR: Average down-regulation of patients with significant down-regulation.  &nbsp;&nbsp;&nbsp;&nbsp;UR: Average up-regulation of patients with significant up-regulation.  &nbsp;&nbsp;&nbsp;% DR: percentage of patients with a significant down-regulation.  &nbsp;&nbsp;&nbsp;% UR: percentage of patients with a significant up-regulation.&nbsp; </FONT></P> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>Analysis of the response to bands of western blots of FE or ME</B>&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>Proliferation.  </B>In order to identify the antigens that stimulate and/or  regulate the mononuclear cell response we studied the response of mononuclear  cells to antigens of FE and ME semi purified by electrophoresis. The protein  pattern is more complex in FE (18 bands) than in ME (14 bands) (<a href="#TABLE_I">Table I</a>).&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">The analysis of patients with relevant proliferation to FE bands (<a href="#fig1">Fig.  1B</a>) shows that bands between 150 and 24.3 kDa (B3 to B18 with the exception  of B4 and B13) gave high CPM (mean relevant CPM higher than 1000) in CDM.  In INF high CPM were observed only with bands 7 (87.3 to 80.1 kDa), 9 (69.8  to 64.6 kDa) and 13 (45.4 to 41.5 kDa). With ME (<a href="#fig1">Fig 1A</a>), the pattern observed  was similar; in CDM the CPM were higher than in INF. and bands 3 and 4  (109.1 to 80.7 kDa), 8 and 9 (53.7 to 47.2 kDa)and 12 (26 to 21.9 kDa)  had higher CPM in CDM. However, the number of bands with mean CPM greater  that 1000 was lower (5 of 14) than with FE (14 of 18). Furthermore none  of the ME bands induced a high proliferation in INF.</FONT></P>     <P ALIGN="center"><a name="fig1"> <img border="0" src="/img/fbpe/ic/v50n1/art09fig1.gif" width="566" height="719"></a></P> </MULTICOL> <MULTICOL GUTTER="31" COLS="2">     
]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">These observations suggest that besides the complexity of the protein pattern,  these sub cellular fractions have fundamental differences in their antigenic  composition.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">The frequency of positive responses to most FE and ME bands (<a href="#fig1">Fig. 1</a>) was  low. Consequently, due to the sample size, any inference concerning the  intensity of the positive response to each band will have a large margin  of error. However, comparing the frequency of relevant proliferation elicited  by each band, we can assess if one experimental group responds more to  one or both sub cellular fractions. The frequency of relevant proliferation  (<a href="#TABLE_IV">Table IV</a>) was significantly higher in CDM (FE p &lt; 0.0001; ME p &lt; 0.0001).  Bands 2, 3, 5, 6, 10, 12, 16, 17 and 18 of FE induced a relevant proliferation  in more than 40% of the CDM. On the other hand in INF only band 2 elicited  a relevant proliferation in more than 40% of the patients. The proliferation  induced by Bands of ME was of lower in intensity, as well as in frequency  of patients with relevant proliferation. Only bands 3, 8, 9 and 11 induced  a relevant proliferation in more than 40% of the CDM and none in INF.</FONT></P> </MULTICOL>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B><a name="TABLE_IV">TABLE IV</a></B></FONT></P>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> PERCENTAGE OF PATIENTS WITH RELEVANT PROLIFERATION INDUCED BY WESTERN  BLOT BANDS OF FLAGELLA AND MEMBRANE&nbsp; </FONT></P>     <div align="center"> <TABLE cellspacing="1" width="579" border="1" id="table4"> <TR> <TD VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Groups&nbsp; </FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="19" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> FE Bands&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> n&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 1&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 2&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 3&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 4&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 9&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 10&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 18&nbsp; </FONT></P> </TD> </TR> <TR> <TD VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> &nbsp;35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 53&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 59&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 53&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 41&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 47&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 24&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 41&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 24&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 41&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 53&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 47&nbsp; </FONT></P> </TD> </TR> <TR> <TD VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 19&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 42&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 32&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 37&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21&nbsp; </FONT></P> </TD> </TR> <TR> <TD VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Groups&nbsp; </FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="19" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> ME Bands&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> N&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 1&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 2&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 3&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 4&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 9&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 10&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 18&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 53&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 24&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 24&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 18&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 41&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 41&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 35&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 53&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 24&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD VALIGN="TOP">     <P ALIGN="LEFT"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 20&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 20&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 20&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 27&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 40&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 27&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 20&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="29" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> </TABLE> </div>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> FE: Flagella epimastigotes. p 0.0001 (CDM vs INF). &nbsp;&nbsp;&nbsp;ME: Membrane epimastigotes.  p 0.0001 (CDM vs INF).&nbsp; </FONT></P> <MULTICOL GUTTER="31" COLS="2"></MULTICOL> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">In summary the response of CDM to bands of FE or ME was more intense and  frequent than in INF. Furthermore, bands of FE elicited a more intense  response than bands of ME. Consequently the discrepancies observed were  not only due to the difference in composition of FE and ME but also to  the characteristic of the immune response of the patients in each group.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>Regulation.  </B>As shown in <a href="#fig2">Fig. 2</a>, with most bands, of FE or ME the mean DR  was similar in both groups. But, the frequency of relevant DR, induced  by bands of FE (<a href="#fig2">Fig.&nbsp;2B</a>) was higher in CDM and this difference was significant  (p = 0.0057). In contrast with the former observation, the frequency of  relevant UR elicited by bands of FE was significantly higher (<a href="#fig2">Fig 2B</a>) in INF, in intensity (p = 0.0001) as well as in frequency (p = 0.028). The  low frequency of UR and the high frequency of DR suggest that the proliferation  observed in CDM with bands of FE principally might be due to proliferation  of regulatory cells.</FONT></P>     <P ALIGN="center"><a name="fig2"> <img border="0" src="/img/fbpe/ic/v50n1/art09fig2.gif" width="563" height="816"></a></P>     
<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">Surprisingly, with ME the intensity of DR, in INF, oscillated more than  with FE (<a href="#fig2">Fig 2 A</a>) and bands 13 and 14 (21.9 to 14.9 kDa) did not induce  an important down regulation in most INF. The frequency of relevant DR  was clearly higher in CDM for all bands. It was of interest that the discordance  between the DR in CDM and INF was more evident with ME than with FE. This  difference was highly significant (p &lt; 0.0001) between CDM and INF (<a href="#TABLE_V">Table  V</a>).In agreement with the low frequency of DR, in INF, with bands of ME,  the frequency of relevant UR, of all ME bands, was higher than 50 per cent.  Most bands of ME induced UR only in a few CDM. The difference between CDM  and INF was highly significant (p &lt; 0.0001) and indicate a clear difference  in the response to ME antigens.</FONT></P></MULTICOL>     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> <B><a name="TABLE_V">TABLE V</a></B></FONT></P>     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> FREQUENCY OF RELEVANT DOWN AND UP REGULATION INDUCED BY WESTERN  BLOT BANDS OF MEMBRANE AND FLAGELLA OF EPIMASTIGOTES OF <I>T. cruzi</I>&nbsp; </FONT></P>     <div align="center"> <TABLE cellspacing="1" width="580" border="1" id="table5"> <TR> <TD WIDTH="27" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="48" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Group</FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> n&nbsp;</FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="18" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> FE</FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 1&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 2&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 3&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 4&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 9&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 10&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 16&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 18&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> DR</FONT></P> </TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 77&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 100&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 93&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 93&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 93&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 43&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 64&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 57&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 79&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 79&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 64&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 71&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> UR</FONT></P> </TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM&nbsp;</FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 43&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 36&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 21&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 29&nbsp; </FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="48" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> Group</FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" ROWSPAN="2" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> n </FONT></P> </TD> <TD VALIGN="TOP" COLSPAN="18" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> ME</FONT></P> </TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 1&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 2&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 3&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 4&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 5&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 7&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 9&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 10&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 11&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 14&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP" BGCOLOR="#c3c3c2"> &nbsp;</TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> DR</FONT></P> </TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 82&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 82&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 88&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 88&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 88&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 88&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 82&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 82&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 88&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 82&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 88&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 76&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 76&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 82&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="48" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 15&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 31&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 31&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 31&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 23&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 31&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 8&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> UR</FONT></P> </TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> CDM </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 17&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 0&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 12&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 6&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> <TR> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="48" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> INF&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 13&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 54&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     ]]></body>
<body><![CDATA[<P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 92&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 77&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 54&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 62&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 77&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP">     <P ALIGN="CENTER"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> 85&nbsp; </FONT></P> </TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> <TD WIDTH="27" VALIGN="TOP"> <font face="Verdana" size="2">&nbsp;</font></TD> </TR> </TABLE> </div>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"> FE: Flagella epimastigotes: &nbsp;&nbsp;Frequency of DR p 0.0057 (CDM vs INF).  &nbsp;&nbsp;Frequency of UR p 0.028 (CDM vs INF). ME: Membrane epimastigotes: Frequency  of DR p 0.0001 (CDM vs INF). &nbsp;&nbsp;Frequency of UR p 0.0001 (CDM vs INF).&nbsp; </FONT></P> <MULTICOL GUTTER="31" COLS="2">     ]]></body>
<body><![CDATA[<P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">The observation that the UR with ME bands was higher in INF and bands that  induce DR in most of CDM, in INF elicited UR in more than 50% of the INF  suggest, in INF, the presence of a balance, between up and down-regulation  that is lost or diminished in CDM.&nbsp; </FONT></P></MULTICOL> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>DISCUSSION&nbsp;</B> </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">In Chagas' disease the host parasite interaction is particularly complex.  It has been reported that in the acute phase as well as in the chronic,  the parasite induce regulation of the immune response. Previously, we have  shown that <I>T. cruzi </I>specifically regulates the immune response (13) and  that there are differences in the proliferation induced in CDM and INF  (5). On the basis of these observations we have postulated that the development  of heart pathology will depend on the dynamic equilibrium between immunopathology  and control of the parasite (30). In a previous paper we have evaluated  the regulation and proliferation induced by soluble antigens of epimastigotes  or trypomastigotes (24). Most bands of either epimastigotes or trypomastigotes  gave a low proliferation in CPM as well in frequency of patients with a  relevant proliferation. None of the CDM showed UR with trypomastigotes  bands but, several of them gave UR in more than 30 percent of the INF.  Our previous data suggests that the cells proliferating might be regulatory  cells more than effectors cells.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">To increase our understanding of the role of different antigens in the  genesis of the immune response to <I>T. cruzi</I> we have evaluated flagella,  which have been reported as protector in experimental animals, and membrane  antigens. FE bands gave a higher proliferative response in a larger percentage  of CDM than of INF. This was surprising; if FE is protector, one would  expect a better response in INF. Furthermore, most FE bands induced DR  in more than 90 percent of CDM, suggesting that the proliferation might  be due to regulatory cells more than effectors cells.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">With ME these observation were more evident. There is a clear difference  between the proliferative response of CDM and INF. As shown in <a href="#fig1">Fig 1</a>, the  proliferation elicited by ME bands in INF was relevant in less than 20  percent of INF. However, all bands gave a significant UR in more than 50  percent of INF. In our opinion the UR observed in INF it is not reflected  as a proliferative response to ME bands because it is inhibited specifically  by regulatory cells. This interpretation is in agreement with recent reports  (15, 16) of a higher frequency of natural regulatory cells CD4+CD25+ in  INF. CD4+CD25+ regulatory cells have been associated with regulation of  immunopathology (31).&nbsp; </FONT></P></MULTICOL> <MULTICOL GUTTER="31" COLS="2">     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">In conclusion the difference of the data obtained in INF and CDM suggests  that the response to these antigens varies according to the clinical status  of patients. The high frequency of UR observed with ME, in INF, implies  the presence of antigens that might be relevant for the immunoprofilaxis  of this disease.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>ACKNOWLEDGEMENTS&nbsp;</B> </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">This work was supported by FONACIT proyecto G2000001530, FONACIT LAB-2000001639  y Consejo de Desarrollo Cientifico y tecnol&#243;gico de la Universidad Central  de Venezuela.&nbsp; </FONT></P>     <P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana"><B>REFERENCES&nbsp;</B> </FONT></P>     <!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">1.&nbsp;<B>WHO.</B> New global effort to eliminate Chagas disease. Weekly Epidemiological  records 2007; 82:259-260.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168420&pid=S0535-5133200900010000900001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">2.&nbsp;<B>Tschudi EI, Anziano DF, Dalmasso AP. </B>Lymphocyte transformation in Chagas  disease. Infect Immun 1972; 6(6):905-908.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168421&pid=S0535-5133200900010000900002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">3.&nbsp;<B>Montufar OM, Musatti CC, Mendes E, Mendes NF. </B>Cellular immunity in chronic  Chagas' disease. J Clin Microbiol 1977; 5(4):401-404.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168422&pid=S0535-5133200900010000900003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">4.&nbsp;<B>Ramos C, Schadtler-Siwon I, Ortiz-Ortiz L. </B>Suppressor cells present in  the spleens of <I>Trypanosoma cruzi</I>-infected mice. J Immunol. 1979; 122(4):1243-1247.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168423&pid=S0535-5133200900010000900004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">5.&nbsp;<B>Mosca W, Plaja J, Hubsch R, Cedillos R. </B>Longitudinal study of immune response  in human Chagas' disease. J Clin Microbiol 1985; 22(3):438-441.&nbsp; </FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168424&pid=S0535-5133200900010000900005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">6.&nbsp;<B>De Titto EH, Braun M, Lazzari JO, Segura EL.</B> Cell-mediated reactivity against  human and <I>Trypanosoma cruzi</I> antigens according to clinical status in Chagas'  disease patients. Immunol Lett 1985; 9(5):249-254.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168425&pid=S0535-5133200900010000900006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">7.&nbsp;<B>Morato MJ, Brener Z, Cancado JR, Nunes RM, Chiari E, Gazzinelli G. </B>Cellular  immune responses of chagasic patients to antigens derived from different <I>Trypanosoma cruzi </I>strains and clones. Am J Trop Med Hyg. 1986; 35(3):505-511.&nbsp; </FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168426&pid=S0535-5133200900010000900007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">8.&nbsp;<B>Scott MT. </B>Delayed hypersensitivity to <I>Trypanosoma cruzi </I>in mice: specific  suppressor cells in chronic infection. Immunology 1981; 44(2):409-417.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168427&pid=S0535-5133200900010000900008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">9.&nbsp;<B>Kierszenbaum F. </B>Immunologic deficiency during experimental Chagas' disease  (<I>Trypanosoma cruzi</I> infection): role of adherent, nonspecific esterase-positive  splenic cells. J Immunol 1982; 129(5): 2202-2205.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168428&pid=S0535-5133200900010000900009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">10.&nbsp;<B>Revelli S, Davila H, Moreno H, Bottasso O. </B>Depressed adjuvant arthritis  in chronically <I>Trypanosoma cruzi</I> infected rats: reversal by cyclophosphamide.  J Rheumatol 1992;19(4):513-516.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168429&pid=S0535-5133200900010000900010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">11.&nbsp;<B>Cardillo F, Falcao RP, Rossi MA, Mengel J. </B>An age-related gamma delta T  cell suppressor activity correlates with the outcome of autoimmunity in  experimental <I>Trypanosoma cruzi </I>infection. Eur J Immunol 1993; 23(10):2597-2605.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168430&pid=S0535-5133200900010000900011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">12.&nbsp;<B>Hoft DF, Lynch RG, Kirchhoff LV. </B>Kinetic analysis of antigen-specific immune  responses in resistant and susceptible mice during infection with <I>Trypanosoma  cruzi.</I> J Immunol 1993; 151(12):7038-7047.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168431&pid=S0535-5133200900010000900012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">13.&nbsp;<B>Mosca W, Briceno L, Hernandez MI. </B>Cell mediated immunity in Chagas' disease. <I>Trypanosoma cruzi</I> antigens induce suppression of the <I>in vitro</I> proliferative  response of mononuclear cells. Mem Inst Oswaldo Cruz 1991;86(2):147-152.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168432&pid=S0535-5133200900010000900013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">14.&nbsp;<B>Reina-San-Martin B, Degrave W, Rougeot C, Cosson A, Chamond N, Cordeiro-Da  Silva, Arala-Chaves M, Coutinho A, Minoprio P. </B>A B-cell mitogen from a  pathogenic trypanosome is a eukaryotic proline racemase. Nat Med. 2000;  6(8):890-897.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168433&pid=S0535-5133200900010000900014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">15.&nbsp;<B>Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho  A, Lage PS, Eloi-Santos SM, Correa-Oliveira R, Martins-Filho DA. </B>Chagasic  patients with indeterminate clinical form of the disease have high frequencies  of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory  T lymphocytes. Scand J Immunol. 2005; 62(3):297-308.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168434&pid=S0535-5133200900010000900015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">16.&nbsp;<B>Vitelli-Avelar DM, Sathler-Avelar R, Massara RL, Borges JD, Lage PS, Lana  M, Teixeira-Carvalho A, Dias JC, Eloi-Santos SM, Martins-Filho DA. </B>Are increased  frequency of macrophage-like and natural killer (NK) cells, together with  high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T  cells, the key to control Chagas' disease morbidity?. Clin Exp Immunol 2006;  145(1):81-92.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168435&pid=S0535-5133200900010000900016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">17.&nbsp;<B>Adorini L, Harvey M, Sercarz EE. </B>The fine specificity of regulatory T cells.  IV. Idiotypic complementarity and antigen-bridging interactions in the  anti-lysozyme response. Eur J Immunol 1979; 9(11):906-909.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168436&pid=S0535-5133200900010000900017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">18.&nbsp;<B>Turkin D, Sercarz EE. </B>Key antigenic determinants in regulation of the immune  response. Proc Natl Acad Sci USA. 1977; 74(9):3984-3987.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168437&pid=S0535-5133200900010000900018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">19.&nbsp;<B>Miller A, Lider O, Weiner HL. </B>Antigen-driven bystander suppression after  oral administration of antigens. J Exp Med. 1991; 174(4):791-798.&nbsp; </FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168438&pid=S0535-5133200900010000900019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">20.&nbsp;<B>Rowland EC, Mikhail KS, McCormick TS. </B>Isotype determination of anti-<I>Trypanosoma  cruzi</I> antibody in murine Chagas' disease. J Parasitol 1992; 78(3):557-561.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168439&pid=S0535-5133200900010000900020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">21.&nbsp;<B>Segura EL, Cura EN, Paulone I, Vasquez C, Cerisola JA. </B>Antigenic makeup  of subcellular fractions of <I>Trypanosoma cruzi.</I> J Protozool 1974; 21(4):571-574.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168440&pid=S0535-5133200900010000900021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">22.&nbsp;<B>Segura EL, Vazquez C, Bronzina A, Campos JM, Cerisola JA, Cappa SM.</B> Antigens  of the subcellular fractions of <I>Trypanosoma cruzi.</I> II. Flagellar and membrane  fraction. J Protozool 1977;24(4): 540-543.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168441&pid=S0535-5133200900010000900022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">23.&nbsp;<B>Ruiz AM, Esteva M, Cabeza Meckert P, Laguens RP, Segura EL. </B>Protective  immunity and pathology induced by inoculation of mice with different subcellular  fractions of <I>Trypanosoma cruzi</I>. Acta Trop 1985; 42(4):299-309.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168442&pid=S0535-5133200900010000900023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">24.&nbsp;<B>Mosca W, Navarro N, Campos Y, Briceno L. </B>Proliferation and bystander suppression  induced by antigens of <I>Trypanosoma cruzi.</I> Evaluation with a modification  of the T cell blot technique. Invest Clin 2006; 47(3):265-282.&nbsp; </FONT> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168443&pid=S0535-5133200900010000900024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">25.&nbsp;<B>Mosca W.</B> Immune response in human Chagas disease II. Lymphocyte blastogenesis  in patients with chagasic cardiomyopathy. Acta Cient Venez 1980; 31(5):  464-467.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168444&pid=S0535-5133200900010000900025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">26.&nbsp;<B>Piras MM, De Rodriguez OO, Piras R. </B><I>Trypanosoma cruzi:</I> antigenic composition  of axonemes and flagellar membranes of epimastigotes cultured <I>in vitro.</I>  Exp Parasitol. 1981; 51(1):59-73.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168445&pid=S0535-5133200900010000900026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">27.&nbsp;<B>Bordier C, Etges RJ, Ward J, Turner MJ, Cardoso de Almeida ML. </B>Leishmania  and Trypanosoma surface glycoproteins have a common glycophospholipid membrane  anchor. Proc Natl Acad Sci USA 1986;83(16):5988-5991.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168446&pid=S0535-5133200900010000900027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">28.&nbsp;<B>Laemmli UK.</B> Cleavage of structural proteins during the assembly of the  head of bacteriophage T4. Nature. 1970; 227 (5259):680-685.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168447&pid=S0535-5133200900010000900028&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">29.&nbsp;<B>Towbin H, Staehelin T, Gordon J. </B>Electrophoretic transfer of proteins from  polyacrylamide gels to nitrocellulose sheets: procedure and some applications.  Proc Natl Acad Sci USA 1979; 76(9):4350-4354.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168448&pid=S0535-5133200900010000900029&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">30.&nbsp;<B>Mosca W.</B> Etiopatogen&#237;a de la enfermedad de Chagas una nueva perspectiva.  Archivos Hosp Vargas 2000; 42:11-17.&nbsp; </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168449&pid=S0535-5133200900010000900030&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><P ALIGN="justify"><FONT COLOR="#1f1a17" SIZE="2" FACE="Verdana">31.&nbsp;<B>Piccirillo CA, Shevach EM.</B> Naturally-occurring CD4+CD25+ immunoregulatory  T cells: central players in the arena of peripheral tolerance. Semin Immunol  2004; 16(2):81-88.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1168450&pid=S0535-5133200900010000900031&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --> ]]></body>
<back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>WHO</collab>
<article-title xml:lang="en"><![CDATA[New global effort to eliminate Chagas disease]]></article-title>
<source><![CDATA[Weekly Epidemiological records]]></source>
<year>2007</year>
<volume>82</volume>
<page-range>259-260</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tschudi]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
<name>
<surname><![CDATA[Anziano]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Dalmasso]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Lymphocyte transformation in Chagas disease]]></article-title>
<source><![CDATA[Infect Immun]]></source>
<year>1972</year>
<volume>6</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>905-908</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montufar]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Musatti]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[NF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cellular immunity in chronic Chagas' disease]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>1977</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>401-404</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Schadtler-Siwon]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz-Ortiz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Suppressor cells present in the spleens of Trypanosoma cruzi-infected mice]]></article-title>
<source><![CDATA[J Immunol.]]></source>
<year>1979</year>
<volume>122</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1243-1247</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Plaja]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hubsch]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cedillos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Longitudinal study of immune response in human Chagas' disease]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>1985</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>438-441</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Titto]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lazzari]]></surname>
<given-names><![CDATA[JO]]></given-names>
</name>
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cell-mediated reactivity against human and Trypanosoma cruzi antigens according to clinical status in Chagas' disease patients]]></article-title>
<source><![CDATA[Immunol Lett]]></source>
<year>1985</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>249-254</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morato]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Brener]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Cancado]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Nunes]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Chiari]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gazzinelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones]]></article-title>
<source><![CDATA[Am J Trop Med Hyg.]]></source>
<year>1986</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>505-511</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Delayed hypersensitivity to Trypanosoma cruzi in mice: specific suppressor cells in chronic infection]]></article-title>
<source><![CDATA[Immunology]]></source>
<year>1981</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>409-417</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kierszenbaum]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells]]></article-title>
<source><![CDATA[J Immunol]]></source>
<year>1982</year>
<volume>129</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>2202-2205</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Revelli]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Davila]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bottasso]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Depressed adjuvant arthritis in chronically Trypanosoma cruzi infected rats: reversal by cyclophosphamide]]></article-title>
<source><![CDATA[J Rheumatol]]></source>
<year>1992</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>513-516</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardillo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Falcao]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mengel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection]]></article-title>
<source><![CDATA[Eur J Immunol]]></source>
<year>1993</year>
<volume>23</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2597-2605</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoft]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Lynch]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Kirchhoff]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi]]></article-title>
<source><![CDATA[J Immunol]]></source>
<year>1993</year>
<volume>151</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>7038-7047</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Briceno]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cell mediated immunity in Chagas' disease.: Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>1991</year>
<volume>86</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>147-152</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reina-San-Martin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Degrave]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Rougeot]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cosson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chamond]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cordeiro-Da]]></surname>
<given-names><![CDATA[Silva]]></given-names>
</name>
<name>
<surname><![CDATA[Arala-Chaves]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Coutinho]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Minoprio]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase]]></article-title>
<source><![CDATA[Nat Med.]]></source>
<year>2000</year>
<volume>6</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>890-897</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vitelli-Avelar]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Sathler-Avelar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Pascoal]]></surname>
<given-names><![CDATA[VP]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira-Carvalho]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lage]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Eloi-Santos]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Correa-Oliveira]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martins-Filho]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes]]></article-title>
<source><![CDATA[Scand J Immunol.]]></source>
<year>2005</year>
<volume>62</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>297-308</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vitelli-Avelar]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Sathler-Avelar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Massara]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Borges]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Lage]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Lana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira-Carvalho]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Eloi-Santos]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Martins-Filho]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?]]></article-title>
<source><![CDATA[Clin Exp Immunol]]></source>
<year>2006</year>
<volume>145</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>81-92</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adorini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Harvey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sercarz]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The fine specificity of regulatory T cells.: IV. Idiotypic complementarity and antigen-bridging interactions in the anti-lysozyme response]]></article-title>
<source><![CDATA[Eur J Immunol]]></source>
<year>1979</year>
<volume>9</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>906-909</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turkin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sercarz]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Key antigenic determinants in regulation of the immune response]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA.]]></source>
<year>1977</year>
<volume>74</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>3984-3987</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lider]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Weiner]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Antigen-driven bystander suppression after oral administration of antigens]]></article-title>
<source><![CDATA[J Exp Med.]]></source>
<year>1991</year>
<volume>174</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>791-798</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rowland]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Mikhail]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[McCormick]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease]]></article-title>
<source><![CDATA[J Parasitol]]></source>
<year>1992</year>
<volume>78</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>557-561</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Cura]]></surname>
<given-names><![CDATA[EN]]></given-names>
</name>
<name>
<surname><![CDATA[Paulone]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Vasquez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cerisola]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Antigenic makeup of subcellular fractions of Trypanosoma cruzi]]></article-title>
<source><![CDATA[J Protozool]]></source>
<year>1974</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>571-574</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Vazquez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bronzina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Cerisola]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Cappa]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Antigens of the subcellular fractions of Trypanosoma cruzi.: II. Flagellar and membrane fraction]]></article-title>
<source><![CDATA[J Protozool]]></source>
<year>1977</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>540-543</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Esteva]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cabeza Meckert]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Laguens]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi]]></article-title>
<source><![CDATA[Acta Trop]]></source>
<year>1985</year>
<volume>42</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>299-309</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Briceno]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Proliferation and bystander suppression induced by antigens of Trypanosoma cruzi.: Evaluation with a modification of the T cell blot technique]]></article-title>
<source><![CDATA[Invest Clin]]></source>
<year>2006</year>
<volume>47</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>265-282</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immune response in human Chagas disease II.: Lymphocyte blastogenesis in patients with chagasic cardiomyopathy]]></article-title>
<source><![CDATA[Acta Cient Venez]]></source>
<year>1980</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>464-467</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piras]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[De Rodriguez]]></surname>
<given-names><![CDATA[OO]]></given-names>
</name>
<name>
<surname><![CDATA[Piras]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Trypanosoma cruzi: antigenic composition of axonemes and flagellar membranes of epimastigotes cultured in vitro]]></article-title>
<source><![CDATA[Exp Parasitol.]]></source>
<year>1981</year>
<volume>51</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>59-73</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bordier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Etges]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cardoso de Almeida]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Leishmania and Trypanosoma surface glycoproteins have a common glycophospholipid membrane anchor]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1986</year>
<volume>83</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>5988-5991</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laemmli]]></surname>
<given-names><![CDATA[UK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cleavage of structural proteins during the assembly of the head of bacteriophage T4]]></article-title>
<source><![CDATA[Nature.]]></source>
<year>1970</year>
<volume>227</volume>
<numero>5259</numero>
<issue>5259</issue>
<page-range>680-685</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Towbin]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Staehelin]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1979</year>
<volume>76</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>4350-4354</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Etiopatogenía de la enfermedad de Chagas una nueva perspectiva]]></article-title>
<source><![CDATA[Archivos Hosp Vargas]]></source>
<year>2000</year>
<volume>42</volume>
<page-range>11-17</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piccirillo]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Shevach]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance]]></article-title>
<source><![CDATA[Semin Immunol]]></source>
<year>2004</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>81-88</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
